NIAID Banner Logo Image

Opportunistic Infections Citation List:

February 17 - March 3, 2010

ANTIFUNGAL COMPOUNDS ( includes Cryptococcus, Aspergillus, Candida, & Histoplasma)

1.In vitro synergistic efficacy of combination of amphotericin B with Myrtus communis essential oil against clinical isolates of Candida albicans. Mahboubi, M. and F. Ghazian Bidgoli. Phytomedicine; PMID[20189786].

[Pubmed]. OI_0217-030310.

2.A novel antifungal anthraquinone from seeds of Aegle marmelos Correa (family Rutaceae). Mishra, B.B., N. Kishore, V.K. Tiwari, D.D. Singh, and V. Tripathi. Fitoterapia. 81(2): p. 104-7; PMID[19686813].

[Pubmed]. OI_0217-030310.

3.Stereospecific synthesis of oximes and oxime ethers of 3-azabicycles: A SAR study towards antimicrobial agents. Parthiban, P., P. Rathika, V. Ramkumar, S.M. Son, and Y.T. Jeong. Bioorg Med Chem Lett. 20(5): p. 1642-1647; PMID[20138517].

[Pubmed]. OI_0217-030310.

4.Synthesis and antimicrobial activities of novel 1,5-diaryl pyrazoles. Ragavan, R.V., V. Vijayakumar, and N.S. Kumari. Eur J Med Chem. 45(3): p. 1173-80; PMID[20053480].

[Pubmed]. OI_0217-030310.

5.Antimicrobial study of newly synthesized 6-substituted indolo[1,2-c]quinazolines. Rohini, R., P. Muralidhar Reddy, K. Shanker, A. Hu, and V. Ravinder. Eur J Med Chem. 45(3): p. 1200-5; PMID[20005020].

[Pubmed]. OI_0217-030310.

6.New 14-membered octaazamacrocyclic complexes: synthesis, spectral, antibacterial and antifungal studies. Singh, D.P., K. Kumar, and C. Sharma. Eur J Med Chem. 45(3): p. 1230-6; PMID[20034706].

[Pubmed]. OI_0217-030310.

7.Identification of Inhibitors of Drug-Resistant Candida albicans Strains from a Library of Bicyclic Peptidomimetic Compounds. Trabocchi, A., C. Mannino, F. Machetti, F. De Bernardis, S. Arancia, R. Cauda, A. Cassone, and A. Guarna. J Med Chem; PMID[20184325].

[Pubmed]. OI_0217-030310.

8.Polymyxin B, in combination with fluconazole, exerts a potent fungicidal effect. Zhai, B., H. Zhou, L. Yang, J. Zhang, K. Jung, C.Z. Giam, X. Xiang, and X. Lin. J Antimicrob Chemother; PMID[20167587].

[Pubmed]. OI_0217-030310.

ANTIBACTERIAL COMPOUNDS (includes Mycobacterium spp., Drug Resistant, MAC, MDR)

9. Novel molecular hybrids of cinnamic acids and guanylhydrazones as potential antitubercular agents. Bairwa, R., M. Kakwani, N.R. Tawari, J. Lalchandani, M.K. Ray, M.G. Rajan, and M.S. Degani. Bioorg Med Chem Lett. 20(5): p. 1623-1625; PMID[20138519].

[Pubmed]. OI_0217-030310.

10. New 1,3-oxazolo[4,5-c]quinoline derivatives: synthesis and evaluation of antibacterial and antituberculosis properties. Eswaran, S., A.V. Adhikari, and R. Ajay Kumar. Eur J Med Chem. 45(3): p. 957-66; PMID[20034708].

[Pubmed]. OI_0217-030310.

11. Calpinactam, a new anti-mycobacterial agent, produced by Mortierella alpina FKI-4905. Koyama, N., S. Kojima, K. Nonaka, R. Masuma, M. Matsumoto, S. Omura, and H. Tomoda. J Antibiot (Tokyo); PMID[20186169].

[Pubmed]. OI_0217-030310.

12. Recent advances toward the inhibition of mAG and LAM synthesis in Mycobacterium tuberculosis. Umesiri, F.E., A.K. Sanki, J. Boucau, D.R. Ronning, and S.J. Sucheck. Med Res Rev. 30(2): p. 290-326; PMID[20099253].

[Pubmed]. OI_0217-030310.

13. Targeting mycobacterium protein tyrosine phosphatase B for antituberculosis agents. Zhou, B., Y. He, X. Zhang, J. Xu, Y. Luo, Y. Wang, S.G. Franzblau, Z. Yang, R.J. Chan, Y. Liu, J. Zheng, and Z.Y. Zhang. Proc Natl Acad Sci U S A; PMID[20167798].

[Pubmed]. OI_0217-030310.

Citations from the ISI Web of Knowledge Listings for O.I.

14. Multiple effects of amprenavir against Candida albicans. Braga-Silva, L.A., S.S.V. Mogami, R.S. Valle, I.D. Silva-Neto, and A.L.S. Santos. Fems Yeast Research. 10(2): p. 221-224; ISI[000274320900011].

[WOS]. OI_0217-030310.

15. Synthesis and in vitro microbiological evaluation of novel 4-aryl-5-isopropoxycarbonyl-6-methyl-3,4-dihydropyrimidinones. Chitra, S., D. Devanathan, and K. Pandiarajan. European Journal of Medicinal Chemistry. 45(1): p. 367-371; ISI[000274203000045].

[WOS]. OI_0217-030310.

16. Salicylanilide carbamates: Antitubercular agents active against multidrug-resistant Mycobacterium tuberculosis strains. Ferriz, J.M., K. Vavrova, F. Kunc, A. Imramovsky, J. Stolarikova, E. Vavrikova, and J. Vinsova. Bioorganic & Medicinal Chemistry. 18(3): p. 1054-1061; ISI[000274153600009].

[WOS]. OI_0217-030310.

17. Catalysis and Inhibition of Mycobacterium tuberculosis Methionine Aminopeptidase. Lu, J.P., S.C. Chai, and Q.Z. Ye. Journal of Medicinal Chemistry. 53(3): p. 1329-1337; ISI[000274270900037].

[WOS]. OI_0217-030310.

18.Discovery of novel antitubercular 2,10-dihydro-4aH-chromeno[3,2-c]pyridin-3-yl derivatives. Sriram, D., P. Yogeeswari, M. Dinakaran, D. Banerjee, P. Bhat, and S. Gadhwal. European Journal of Medicinal Chemistry. 45(1): p. 120-123; ISI[000274203000016].

[WOS]. OI_0217-030310.

If using ChemDB information for publication or abstract presentation, please cite the website in addition to the original information source.    Database last updated: May 2021